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duplex and CTA with complete unilateral carotid occlu-
sion between 2000 and 2009. CTA was used to obtain
diameter and cross-sectional area measurements of ca-
rotid stenosis. Percent stenosis was calculated using the
NASCET technique with both diameter and cross-sec-
tional area measurements. Pearson’s correlation coeffi-
cients were generated to detect congruency between
duplex velocity, diameter-derived stenosis, and cross-
sectional area-derived stenosis.
Results: A total of 20 patients were included. Correla-
tion coefficients for diameter-based stenosis were: r 
0.698 (P .001) for 50% stenosis, r 0.375 (P .103)
for 50% to 79% stenosis, and r  0.490 (P  .028) for 
80%. Correlation coefficients for cross-sectional area mea-
surement were: r  0.903 (P .001) for  50% stenosis,
r  0.802 (P .001) for 50% to 79% stenosis, and r 
0.866 (P .001) for  80% stenosis.
Conclusions: In the setting of contralateral carotid
artery occlusion, duplex ultrasound had a higher correla-
tion with cross-sectional area-derived stenosis than with
traditional diameter-derived measurements on CTA. For
this subgroup of patients, cross-sectional area measure-
ments may be more reflective of the duplex-derived data
due to the ability of CTA to delineate more complex
carotid bulb anatomy. Additional studies are needed to
correlate cross-sectional data and clinical outcomes.
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close; A. Chandra: Nothing to disclose; A. J. Doyle:
Nothing to disclose; D. Gillespie: Nothing to disclose;
B. Jahromi: Nothing to disclose; J. Kim: Nothing to
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Non-operative Treatment of Spontaneous Visceral Ar-
tery Dissection
Eileen de Grandis, Adam Power, Manju Kalra, Robert
McBane, Christine Lohse, Thomas C. Bower.Mayo Clinic,
Rochester, MN
Objectives: Spontaneous visceral artery dissection
(SVAD) is rare, and little is known about its natural history.
Our goal is to determine early and late outcomes of patients
managed non-operatively.
Methods: A retrospective review of all consecutive
patients with visceral artery dissection confirmed by imag-
ing from 1990 to 2011. Patients with SVAD associated
with fibromuscular disease, vasculitis, and iatrogenic or
traumatic injury were excluded.
Results: Sixty-one men and 28 women ( mean age 54
/- 12 years ) were treated for SVAD over 20 years.
Eighty-one patients were Caucasian (96%); comorbidities
included hypertension (60%), hyperlipidemia (47%), and
smoking (45%). Sixty patients (67%) presented with ab-
dominal pain or GI symptoms; 29 were asymptomatic
(33%) with dissection discovered incidentally. Diagnosis
was confirmed by CTA in most patients. SVAD involved an
average of 2.4 /- 2.2 vessels per patient with celiac
territory involvement in 61%, SMA in 43%, and both in
27%. AverageWBCwas 7.9 (Normal range 4-10), CRP 4.9
(Normal 10), and ESR 16.5 (Normal 20). Seventy-
three patients were managed successfully medically with
initiation of anti-hypertensives in 22 (25%), anti-coagula-
tion in 21 (24%), and aspirin in 14 (16%). Seventeen (19%)
patients underwent intervention (13 surgical, 4 coil embo-
lization) at diagnosis; 6 for rupture, 7 for worsening symp-
toms, and 4 for enlarging aneurysms or dissections. There
were no peri-procedural deaths within 30 days. Six patients
died over a mean follow-up of 5.9 /- 3.2 years. On
surveillance imaging, the majority of dissections remained
stable or resolved. Estimated survival at 1, 3, 5, and 10 years
was 100%, 94%, 94%, and 65%.
Conclusions: SVAD is a rare disease. Most Caucasian
patients with this problem can be treated medically with
good long-term survival. Operation and/or endovascular
therapy is necessary for rupture or persistent symptoms
despite maximum medical therapy.
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de Grandis: Nothing to disclose; M. Kalra: Nothing to
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Nonoperative Management of Isolated Spontaneous
Dissection of the Renal Artery
AdamH. Power, Thomas C. Bower,Manju Kalra, Audra A.
Duncan, Gustavo S. Oderich, Robert McBane, Eddie
Greene, Peter Gloviczki. Vascular and Endovascular Sur-
gery, Mayo Clinic, Rochester, MN
Objectives: Isolated spontaneous dissection of the re-
nal artery (ISDRA) is rare and the preferred treatment is
undefined. Open and endovascular approaches have had
mixed results and there is little data on nonoperative man-
agement. Our objective was to assess the management of
ISDRA with emphasis on those treated without operative
intervention.
Methods: All patients with ISDRA were reviewed at a
single institution from 1995 to 2010.
Results: Forty-three patients were treated with 55
ISDRA. Thirty-five were males (81%), 41 were Cauca-
sian (91%), and the mean age was 46.2 years (range,
29-72). Forty-one patients presented with abdominal or
flank pain (95%) and only 3 had pre-existing hyperten-
sion (7%). The mean time from symptoms to diagnosis
was 7.8 days (range, 1-60). Initial mean creatinine (Cr)
was 1.1 mg/dL. Most patients were diagnosed with
computed tomography (n39, 91%). No other dissec-
tions were initially identified based on available imaging
studies. The dissection involved the main renal artery in
44 (80%), a segmental branch in 40 (73%), and ipsilateral
multiple branches in 23 (42%). Thirty-seven patients
JOURNAL OF VASCULAR SURGERY
June Supplement 201272S Abstracts
(67%) had a minor infarct (25% of cortex), 9 (16%)
moderate (25-50% of cortex), and 2 (4%) severe (50%
of cortex). All but one patient were treated nonopera-
tively, using anticoagulation in 36 patients (86%) for a
mean duration of 5.7 months (range 1-24), life-long
aspirin therapy in 29 (69%), and blood pressure control
in 35 (83%). An attempt at ex-vivo repair in the operative
patient failed. Thirty-four patients (81%) developed new
onset of HTN within 1 year and were on 1.1 (range, 0-3)
antihypertensive medications at 1 year. Three patients
(7%) had a recurrent dissection, 41 (98%) had a normal
creatinine, and no patient died or required dialysis over a
mean follow-up of 35 months (range 0-279).
Conclusions: Nonoperative management of ISDRA is
feasible and safe in most patients.
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Skeletal Muscle Damage in Critical Limb Ischemia
(CLI) Is Mediated via the MyD88-Dependent Signal-
ling Pathway
Hemanshu Patel1, George Hamilton1, David Abraham1,
Daryll Baker1, Sidney Shaw2, Janice Tsui1. 1Division of
Surgery & Interventional Science, UCL, London, United
Kingdom; 2University of Bern, Bern, Switzerland
Objectives: Critical limb ischemia is associated with
skeletal muscle damage and tissue loss, however its patho-
physiology is poorly understood. Toll-like receptors
(TLRs) have been implicated in iscaemia-induced tissue
damage. TLR 2 & 6 in particular have been implicated in
critically ischemic muscle. Two separate signalling path-
ways exist for the signalling transduction of TLRs: the
MyD88-dependent pathway and the MyD88-independen
pathway. We aim to investigate which TLR signalling path-
ways are involved in ischemia-induced muscle damage. We
hypothesize that skeletal muscle ischemia induces TLR 2&
6 heterodimerisation and activation of the MyD88 depen-
dent pathway resulting in cytokine-mediated muscle
damage.
Methods: TLR 2 and 6 expression in ischemic and
control human muscle biopsies and in C2C12 myotubes
cultured in ischemic conditions were studied usingWestern
blot and immunohistochemistry. TLR 2& 6 heterodimeri-
sation was confirmed by co-immunoprecipitation. Func-
tional effects of TLR 2/6 and MyD88 antagonism on
ischemia-induced IL-6 release and apoptosis were studied
with neutralizing TLR 2/6 antibodies and aMyD88 inhib-
itor. IL-6 release was assayed by ELISA and apoptosis was
assessed using cleaved caspase-3.
Results: TLR 2 and 6 protein expression was signif-
icantly upregulated in ischemic muscle and ischemic
C2C12 myotubes (P.05). TLR 2 and 6 heterodimerise
under ischemic conditions with consequent activation of
the signaling pathway. Ischemia-induced IL-6 produc-
tion and apoptosis were reduced by TLR 2/6 antago-
nism and MyD88 inhibition.
Conclusions:Upregulation of TLR 2 and 6 expression
occurs in CLI. Heterodimerisation of TLR 2 and TLR 6
and the subsequent activation of the signaling pathway
results in IL-6 release and apoptosis which contributes to
inflammation and muscle damage in ischemia. Further we
have provided novel evidence that the MyD88 dependent
pathway is critical in the signalling process and maybe a
potential therapeutic target.
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Lung Endothelial Cell Apoptosis during Ischemic
Acute Kidney Injury
Laura E. White1, Yan Cui1, Carolyn M. Feltes Shelak3,
Heitham T. Hassoun2. 1The Methodist Hospital and Re-
search Institute, Houston, TX; 2The Methodist Hospital
and Research Institute and The Methodist DeBakey Heart
& Vascular Center, Houston, TX; 3The Johns Hopkins
School of Medicine, Baltimore, MD
Objectives: Despite advancements in renal replace-
ment therapy, mortality with acute kidney injury(AKI)
remains high, likely due to remote organ injury. Kidney
ischemia-reperfusion injury(IRI) activates cellular and soluble
mediators, driving lung inflammation, TNFR1-mediated ap-
optosis and microvascular barrier dysfunction. We hypothe-
sized that lung microvascular endothelial cells(ECs), with
their integral role maintaining the lung semipermeable bar-
rier, were key cellular targets of TNFR1-mediated apoptosis
during ischemic AKI.
Methods: Male C57/BL6 mice and Sprague-Dawley
rats underwent 60min bilateral renal pedicle occlusion(IRI)
or sham laparotomy(sham) and sacrifice at 4 or 24hrs.
TUNEL/DAPI/CD34 colocalization identified EC apo-
ptosis in vivo and ECs[CD45-/CD31] isolated by novel
techniques underwent RT-PCR Apoptosis SuperArray
analysis. In parallel, rat lung microvascular ECs(RLM-
VECs) treated with serum from rats after sham or IRI
underwent custom RT-PCR analysis for apoptosis and
TNF family gene transcription; capase-3 and PARP activity
assays identified RLMVEC apoptosis. Separately, inflam-
matory genes and apoptosis were compared in RLMVECs
treated with TNF/TNFR1 signaling inhibition (Etaner-
cept vs vehicle) during ischemic AKI.
Results: In vivo, TUNEL cells colocalized with
CD34 during ischemic AKI and isolated lung ECs demon-
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